Showing results (261-270 of 1,040) with videos related to
Sort By:
Pageof 104
Personalized Medicine|August 11, 2015
Performance of exome sequencing for pharmacogenomicsEric R Londin, Peter Clark, Marialuisa Sponziello, et al.Personalized Medicine|May 11, 2018
CA 15-3 predicting breast cancer relapse: beware of vitamin B12 deficiencyElie El Rassy, Maya Al Ghor, Joseph KattanPersonalized Medicine|May 12, 2018
European healthcare systems readiness to shift from 'one-size fits all' to personalized medicineSebastian Schee Genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck, et al.Personalized Medicine|May 12, 2018
Enabling personalized medicine in Europe by the European Commission's funding activitiesElmar Nimmesgern, Irene Norstedt, Ruxandra Draghia-AkliPersonalized Medicine|May 12, 2018
Participants' decision to enroll in cohort studies with biobanks: quantitative insights from two German studiesHélène Nobile, Pascal Borry, Tobias Pischon, et al.Personalized Medicine|May 12, 2018
Incorporating the 'Theory of Planned Behavior' into personalized healthcare behavior change research: a call to actionJustine Horne, Janet Madill, Jason GillilandPersonalized Medicine|May 12, 2018
Portero versus portador: Spanish interpretation of genomic terminology during whole exome sequencing results disclosureAmanda M Gutierrez, Jill O Robinson, Emily E Statham, et al.Personalized Medicine|May 12, 2018
An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacistsRowan AlEjielat, Zeyad Ejielat, Shireen Andrawes, et al.Personalized Medicine|May 12, 2018
rs9263726 is a specific genetic marker for allopurinol-induced severe cutaneous adverse reactions in Chinese patientsZhiyao Chen, Shichao Zhang, Jingjing Zhang, et al.Personalized Medicine|May 20, 2018
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifenNigel Fleeman, Katherine Payne, William G Newman, et al.Pageof 104